PDE / ADE · OEL / OEB

Home→PDE/ADE · OEL/OEB Profiles → Azidamfenicol→

Azidamfenicol PDE report and OEL report profile

Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.

CAS Registry Number
13838-08-9
Molecular formula
C11H13N5O5
Molecular weight
295.25 g/mol
Drug class
Amphenicol antibacterialchloramphenicol-related protein-synthesis inhibitor
Mechanism of action
Binds the 50S ribosomal subunit and inhibits peptidyl transferase activity, impairing bacterial protein synthesis. Antibacterial spectrum and clinical role depend on the specific formulation and local susceptibility.
Indications / reported uses
  • Historical or regional treatment of susceptible bacterial infections with topical or ophthalmic formulations where authorised; current availability and use are jurisdiction-specific

Sources: NLM MeSH — Azidamfenicol · PubMed — Azidamfenicol antibacterial pharmacology · FDA product information

View request basketPrefer email? info@toxwriter.com
PDE / ADE derivationOEL derivationOEB / OHC banding
Assessment scope

PDE/ADE and OEL/OEB assessment

ToxWriter provides project-specific support for Azidamfenicol PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Azidamfenicol Permitted Daily Exposure (PDE) report (the Azidamfenicol PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Azidamfenicol Occupational Exposure Limit (OEL) report (the Azidamfenicol OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.

Assessment may cover

  • PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
  • OEL derivation considering relevant hazards, exposure route, duration and workplace conditions.
  • OEB/OHC banding where requested and supported by the evidence; an exposure band is not a numerical OEL.
  • Review of substance identity, evidence quality, uncertainty and data gaps.
PDE/ADE, OEL & OEB/OHC regulatory framework

The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.